Next, we evaluated whether TSP-2 gene therapy could inhibit TSP-1 mediated TGF-β activation in the rat CAN model as demonstrated before in the anti-Thy1 model (16). The gene discussed is THBS1; the disease is Crouzon syndrome-acanthosis nigricans syndrome.